Press Release

Chennai, May 20, 2020 – CPC Diagnostics (‘CPC’), Chennai, a portfolio company of Everstone backedhealthcare platform Everlife Holdings Pte. Ltd (‘Everlife’), has launched SARS COV-2 IgM and SARSCOV-2 IgG tests in India. Both are CE-approved antibody tests and are the first of their kind to getapproved by the Indian Council of Medical Research (‘ICMR’). The …

CPC Diagnostics launches first ICMR approved COVID-19 CLIA antibody test in India Read More »

October, 2019 – Chemopharm Sdn Bhd, an Everlife investment and leading laboratory and medical devices distributor headquartered in Malaysia, is proud to be appointed the exclusive distributor of PAC’s Physical Properties Testing and Elemental Analysis products in Malaysia, which includes the Alcor, Antek, Herzog, ISL, PAC and Phase Technology brands. This is an extension of …

Chemopharm appointed as Exclusive Channel Partner of PAC in Malaysia Read More »

Founded in 2014, the Asia Pacific Medical Technology Association (APACMed) represents manufacturers and suppliers of medical equipment, devices and in-vitro diagnostics, industry associations and other key stakeholders associated with the medical technology industry in Asia Pacific. Headquartered in Singapore, APACMed is the first and only regional association to provide a unified voice for the medical …

Everlife joins the Asia Pacific Medical Technology Association (APACMed)! Read More »

April, 2019 – Chemopharm Sdn Bhd, an Everlife investment and leading laboratory and medical devices distributor headquartered in Malaysia, is pleased to announce the completion of an asset purchase for Mindray hematology and clinical chemistry analyzers from Histocenter (M) Sdn Bhd in Malaysia. Chemopharm has an existing agreement with Mindray to distribute the leading Chinese …

Chemopharm announces expanded distribution partnership with Mindray in Malaysia Read More »

April 2019 – CPC Diagnostics, a leading IVD manufacturer and distributor in India, and YHLO, a leading company for immunoassays in China, jointly held a product launch ceremony in Chennai to introduce YHLO’s iFlash CLIA System to the Indian market. CPC Diagnostics was appointed as YHLO’s exclusive partner to commercialize their iFlash CLIA System in …

CPC Diagnostics and YHLO jointly launch iFlash CLIA System in India Read More »

Mumbai, March 13, 2019 – The Everstone Group via its healthcare platform Everlife has acquired a stake in Chennai based CPC Diagnostics, to include core in-vitro diagnostics (IVD) segments in its portfolio of medical devices and extend its geographical presence to India, with this first investment in the country. Founded in 1987, CPC Diagnostics (“CPC”) is …

Everstone-backed Everlife invests in Chennai based CPC Diagnostics Read More »

Originally published on Everstone website here. Singapore, November 23, 2017 – The Everstone Group via its platform Everlife has acquired Malaysia-based Chemopharm Sdn Bhd., a leading provider of products and services’ solutions to laboratory, research and medical facilities in Southeast Asia. Singapore-based Cure Capital is a co-investor, along with Everstone. Founded in 1976, Chemopharm Sdn Bhd. …

Everstone invests in Chemopharm, a leading Southeast Asian distributor of medical products and solutions Read More »